IM Cannabis Corp. (IMCC), a medical cannabis company, Tuesday announced that it is evaluating strategic opportunities to enter the US cannabis market after President Trump's executive order signed on December 18, directing the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act.
To advance its entry into the US market the company has engaged the services of SSC Advisors who are expected provide customary financial advisory services, including strategic guidance on potential U.S. cannabis market entry and the identification of prospective partners or acquirors.
In pre-market activity, IMCC shares were trading at $1.51, up 9.42% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.